Invesco Dorsey Wright Healthcare Momentum ETF
Registrant
Invesco Exchange-Traded Fund Trust
Class ticker
Net Assets
$120,908,517
Holdings
58
Latest Report
Apr 30, 2026
Holdings · 58
Export CSV
Showing 1–50
of 58 holdings by value
· page 1 of 2
| Holding | Symbol | Balance | Value | % of Fund | Side | Category | Open |
|---|---|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | PRAX | 19,267 | $6,142,898 | 5.08% | Long | EC | |
| Roivant Sciences Ltd. | ROIV | 197,099 | $5,623,234 | 4.65% | Long | EC | |
| United Therapeutics Corp. | UTHR | 7,268 | $4,152,572 | 3.43% | Long | EC | |
| Tenet Healthcare Corp. | THC | 20,745 | $3,674,354 | 3.04% | Long | EC | |
|
Terns Pharmaceuticals, Inc.
|
880881107 | 65,368 | $3,459,928 | 2.86% | Long | EC | |
| Tango Therapeutics Inc. | TNGX | 159,490 | $3,448,174 | 2.85% | Long | EC | |
| HCA Healthcare, Inc. | HCA | 7,728 | $3,357,430 | 2.78% | Long | EC | |
| Axsome Therapeutics, Inc. | AXSM | 15,385 | $3,196,234 | 2.64% | Long | EC | |
| Nektar Therapeutics | NKTR | 36,570 | $3,109,913 | 2.57% | Long | EC | |
| Celcuity Inc. | CELC | 25,182 | $3,055,836 | 2.53% | Long | EC | |
| Ionis Pharmaceuticals, Inc. | IONS | 38,394 | $2,870,335 | 2.37% | Long | EC | |
| Capricor Therapeutics, Inc. | CAPR | 81,402 | $2,733,479 | 2.26% | Long | EC | |
| Cencora, Inc. | COR | 8,829 | $2,719,420 | 2.25% | Long | EC | |
| Alumis Inc. | ALMS | 103,872 | $2,564,600 | 2.12% | Long | EC | |
| Gilead Sciences, Inc. | GILD | 18,363 | $2,402,615 | 1.99% | Long | EC | |
| Kodiak Sciences Inc. | KOD | 55,223 | $2,401,096 | 1.99% | Long | EC | |
| BrightSpring Health Services, Inc. | BTSG | 49,825 | $2,390,105 | 1.98% | Long | EC | |
| Jazz Pharmaceuticals PLC | JAZZ | 11,426 | $2,319,707 | 1.92% | Long | EC | |
| Moderna, Inc. | MRNA | 50,080 | $2,300,675 | 1.90% | Long | EC | |
| Protagonist Therapeutics, Inc. | PTGX | 23,165 | $2,292,640 | 1.90% | Long | EC | |
| Viatris Inc. | VTRS | 152,008 | $2,271,000 | 1.88% | Long | EC | |
| Dianthus Therapeutics, Inc. | DNTH | 24,726 | $2,170,943 | 1.80% | Long | EC | |
| AnaptysBio, Inc. | ANAB | 32,708 | $2,149,897 | 1.78% | Long | EC | |
| Ensign Group, Inc. (The) | ENSG | 11,223 | $2,095,222 | 1.73% | Long | EC | |
| Incyte Corp. | INCY | 21,763 | $2,073,361 | 1.71% | Long | EC | |
| Erasca, Inc. | ERAS | 194,096 | $2,067,122 | 1.71% | Long | EC | |
| Ligand Pharmaceuticals Inc. | LGND | 8,520 | $1,954,914 | 1.62% | Long | EC | |
| Oruka Therapeutics, Inc. | ORKA | 28,323 | $1,937,576 | 1.60% | Long | EC | |
| CG Oncology, Inc. | CGON | 28,115 | $1,876,395 | 1.55% | Long | EC | |
| Tyra Biosciences, Inc. | TYRA | 53,591 | $1,862,287 | 1.54% | Long | EC | |
| SELLAS Life Sciences Group, Inc. | SLS | 367,216 | $1,817,719 | 1.50% | Long | EC | |
| Spyre Therapeutics, Inc. | SYRE | 24,120 | $1,795,734 | 1.49% | Long | EC | |
| Kymera Therapeutics, Inc. | KYMR | 21,835 | $1,770,163 | 1.46% | Long | EC | |
| Twist Bioscience Corp. | TWST | 30,064 | $1,757,241 | 1.45% | Long | EC | |
| Liquidia Corp. | LQDA | 43,673 | $1,712,418 | 1.42% | Long | EC | |
| Brookdale Senior Living Inc. | BKD | 118,923 | $1,707,734 | 1.41% | Long | EC | |
| Axogen, Inc. | AXGN | 38,310 | $1,654,992 | 1.37% | Long | EC | |
| Exelixis, Inc. | EXEL | 36,251 | $1,611,719 | 1.33% | Long | EC | |
| Edgewise Therapeutics, Inc. | EWTX | 51,209 | $1,585,431 | 1.31% | Long | EC | |
| Trevi Therapeutics, Inc. | TRVI | 114,114 | $1,570,209 | 1.30% | Long | EC | |
| Cytokinetics, Inc. | CYTK | 22,459 | $1,436,702 | 1.19% | Long | EC | |
| Elanco Animal Health Inc. | ELAN | 62,951 | $1,408,214 | 1.16% | Long | EC | |
| Relay Therapeutics, Inc. | RLAY | 105,574 | $1,368,239 | 1.13% | Long | EC | |
| Dyne Therapeutics, Inc. | DYN | 77,358 | $1,357,633 | 1.12% | Long | EC | |
| Vaxcyte, Inc. | PCVX | 23,663 | $1,354,470 | 1.12% | Long | EC | |
| Krystal Biotech, Inc. | KRYS | 5,073 | $1,330,445 | 1.10% | Long | EC | |
| Enliven Therapeutics, Inc. | ELVN | 31,343 | $1,292,272 | 1.07% | Long | EC | |
| Arcus Biosciences, Inc. | RCUS | 44,685 | $1,139,468 | 0.94% | Long | EC | |
| Annexon, Inc. | ANNX | 188,931 | $1,109,025 | 0.92% | Long | EC | |
| Stoke Therapeutics, Inc. | STOK | 33,715 | $1,103,155 | 0.91% | Long | EC |